Background:
INTRODUCTION
Approximately 3% of the world population is infected with hepatitis C virus. Protein of the hepatitis C virus modulates apoptosis and steatosis, liver cell Around 10-20% will develop into liver cirrhosis and hepatocellular carcinoma. While the body immune system tries to eliminate the virus, liver cells injury cytokines.
1,2 Hepatitis C virus infection will cause injury to the hepatocytes. This injury to the hepatocytes will activate liver stellate cells. Activated stellate cells reaction of granulation tissue development which is associated with injury to the liver parenchyma cells and occurs in the long-term. Fibrogenic response is marked by the accumulation of extracellular matrix be achieved by ceasing the chronic injury process towards the liver cells. By ceasing the injury to liver 3 Although it has been known that other mesenchymal liver cells also contribute in the accumulation of extracellular matrix, stellate cells activation pathway is still considered as the response towards liver tissue injury. 4 These cells have effort to the identify active stellate cells is an important thing in the process of understanding pathogenesis, 5 Stellate liver cell itself is a mesenchymal cell in the liver that has high degree of heterogenicity and plasticity; therefore it contains many compounds immunohistochemical staining. One of the potential immunohistochemical marker is CD38+, this is a cell membrane molecule of the active liver stellate cells which has been known to be expressed in rats' liver stellate cells in vitro and in vivo. [4] [5] [6] [7] A study performed by Abdeen et al in chronic hepatitis patients revealed that CD38+ staining could be used to identify liver stellate cells and was a strong predictor for moderate al in chronic hepatitis C patients proved that CD38+ liver stellate cells count was strongly correlated with 8 In identifying METAVIR fibrosis score from mild to severe, CD38+ staining technique has better . 77.27% with lower sensitivity, which was 90% vs. 95%. Additionally, the positive predictive value of of chronic hepatitis C (CHC) virus affects the injury in hepatocytes. This number of CHC virus is measured in the form of quantitative HCV RNA. Hepatocyte cell which is injured will release transaminase enzyme in the form of aspartate aminotransferase (AST) and alanine aminotransferase glutamic (ALT) which can be measured in the blood. 4 According to Sandulescu et al, there was weak association between ALT and active liver stellate cells in chronic hepatitis C. 9, 10 In the last few years, studies using CD38+ as a liver stellate cells marker was still rarely performed. This study aimed to identify the association between CD38+ liver stellate cells count and several clinical parameters in CHC RNA, AST and ALT values.
METHOD
This study was an observational analytic study and used cross sectional study design. Research would be performed in Cipto Mangunkusumo Hospital by analysing medical records. Target population in this study was chronic hepatitis C patients. Inclusion criteria in this study were chronic hepatitis C patients who had undergone biopsy, patient gave consent to participate in the study. Exclusion criteria of this study were presence of hepatocellular carcinoma in patients, hepatoprotector drugs consumption, viral infection which could increase AST-ALT, diabetes mellitus, fatty liver, not currently suffering from typhoid fever; not currently suffering from pulmonary tuberculosis. All samples included in this study would receive explanation before hand on the objectives, procedures to be performed, and complications that might happen in this study. Samples could only participate if they had given written consent. Variables that would be evaluated were number of ALT value, and quantitative HCV RNA.
Samples are study subjects who are part of the and exclusion criteria. Study samples were collected by identifying data of chronic hepatitis C patients who had undergone liver ultrasonography (USG), did not suffer from hepatoma, and had undergone liver 
RESULTS
A total of 32 biopsy preparations of chronic hepatitis C patients, which consisted of 20 males and 12 females were included in this study. Patients aged more than 40 years old were 16 patients and those aged below 40 were 16 patients. Table 1 showed the distribution of subjects' characteristics based on sex and age. In this study, we reported no correlation found between CD38+ stellate liver cells with AST (p = 0.2) or even ALT (p = 0.7) value. with the number of active liver stellate cells. 1 In that study, it was concluded that activated liver stellate cells liver cirrhosis in chronic hepatitis C patients.
Results of correlation analysis between CD38+ liver stellate cells and AST in chronic hepatitis C patients in this study showed that there was no correlation between AST and number of CD38+ liver stellate cells in chronic hepatitis C patients (p = 0.20). Study conducted by Nadeem et al in 107 non-cirrhotic hepatitis C patients and had not received treatment for hepatitis C revealed that there was no association between AST showed that there was no correlation between AST value and number of CD38+ liver stellate cells. 11 This to represent condition of the liver but also that of the heart, skeletal muscle, kidney, brain, and red blood cells. 12 Meanwhile, for correlation analysis between CD38+ liver stellate cells and ALT in chronic hepatitis C patients that hepatocellular injury could lead to the release of cytosol alanine transaminase enzyme into the blood circulation. ALT value is often used as a marker of liver injury in chronic hepatitis C patients, which include assessment to progressivity, evaluation of therapy and prognosis. 13 In this study, the obtained results showed that there was no correlation between ALT and number of CD38+ liver stellate cells in chronic hepatitis C patients (p = 0.70). Study performed by Pradat et al to 864 positive HCV RNA patients with normal ALT value for 6 months which was measured from the time of liver tissue collection to ALT value before administration of therapy.
14 Normal ALT value normal value which was obtained for 6 months. The study revealed that there was no correlation between C patients before receiving therapy. This could be caused by the activity of ALT which changes easily, sex, body mass index. In chronic hepatitis C patients, liver cell death can occur through apoptosis and necrosis, thus the cells that are almost dead produce less ALT. This explains why there was weak correlation 13 Puoti et al also studied 46 carrier hepatitis C patients with persistent normal ALT and compared them with 52 positive HCV RNA patients with increased ALT value. 15 Results of this study revealed that there was no difference between patients with normal ALT value and patients with increased ALT value, therefore it was concluded that there was no correlation between the and ALT value, indirectly it showed that there was no correlation between CD38+ liver stellate cells and ALT value. Number of publications which opposed this assertion encouraged Kyrlagkitsis et al to conduct a retrospective study to 91 chronic hepatitis C patients with persistent normal ALT value and to 94 patients with abnormal liver biochemistry by comparing liver histology appearance from each groups. 16 Development
Researchers reported one from six chronic hepatitis C experienced progressive liver disease. They also found compared to patients with abnormal ALT value.
13
Assessment of correlation between quantitative HCV RNA and CD38+ liver stellate cells in chronic hepatitis C patients showed that there was no correlation between quantitative HCV RNA and CD38+ liver stellate cells. This was similar with the cohort study conducted by Fanning et al to 77 chronic hepatitis C patients by monitoring clinical parameter, biochemistry, and histology. 17 The results of the study revealed that there was no significant correlation between quantitative HCV RNA with degree of liver 17 Study performed by Romeo et al also reported similar result. The study was conducted to 170 chronic hepatitis C patients and 27 hepatocellular carcinoma patients who had undergone liver biopsy. The results of the study exhibited that advancement of hepatitis C disease was not associated with genotype difference or HCV RNA level. 18 Deterioration of hepatitis C disease was in accordance with the development of the increase of liver stellate cells. Hence, we could conclude that HCV RNA level was not correlated with liver stellate cells. 
